Automatic detection of misleading blood flow values in CT perfusion studies of lung cancer
暂无分享,去创建一个
Alessandro Bevilacqua | Domenico Barone | Silvia Malavasi | Giampaolo Gavelli | A. Bevilacqua | D. Barone | G. Gavelli | Silvia Malavasi
[1] Alessandro Bevilacqua,et al. Quantitative assessment of effects of motion compensation for liver and lung tumors in CT perfusion. , 2014, Academic radiology.
[2] J. Remy,et al. Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and anti-angiogenic chemotherapy , 2013, European Radiology.
[3] A. Chandler,et al. Reproducibility of CT perfusion parameters in liver tumors and normal liver. , 2011, Radiology.
[4] T. Frauenfelder,et al. Assessment of Bronchial and Pulmonary Blood Supply in Non-Small Cell Lung Cancer Subtypes Using Computed Tomography Perfusion , 2015, Investigative radiology.
[5] F. Zaccagna,et al. Whole-tumour CT-perfusion of unresectable lung cancer for the monitoring of anti-angiogenetic chemotherapy effects. , 2013, The British journal of radiology.
[6] L. Goldman. Principles of CT and CT Technology* , 2007, Journal of Nuclear Medicine Technology.
[7] M. Bellomi,et al. CT perfusion in solid-body tumours. Part I: technical issues , 2010, La radiologia medica.
[8] B. Seifert,et al. Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CT , 2014, EJNMMI Research.
[9] Thomas E Yankeelov,et al. Methods and challenges in quantitative imaging biomarker development. , 2015, Academic radiology.
[10] C. Thng,et al. Dynamic contrast-enhanced CT imaging of hepatocellular carcinoma in cirrhosis: feasibility of a prolonged dual-phase imaging protocol with tracer kinetics modeling , 2009, European Radiology.
[11] Yue Cao,et al. Correction of arterial input function in dynamic contrast‐enhanced MRI of the liver , 2012, Journal of magnetic resonance imaging : JMRI.
[12] Eric A Hoffman,et al. Pulmonary perfused blood volume with dual-energy CT as surrogate for pulmonary perfusion assessed with dynamic multidetector CT. , 2013, Radiology.
[13] M. P. Hayball,et al. Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography , 2012, European Radiology.
[14] G. Zack,et al. Automatic measurement of sister chromatid exchange frequency. , 1977, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[15] Alessandro Bevilacqua,et al. Computer assisted detection of regions of interest in histopathology using a hybrid supervised and unsupervised approach , 2013, Medical Imaging.
[16] S. Sironi,et al. Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging , 2012, European Radiology.
[17] G J M Parker,et al. Comparison of dynamic contrast‐enhanced MRI and dynamic contrast‐enhanced CT biomarkers in bladder cancer , 2011, Magnetic resonance in medicine.
[18] Agostino Gibaldi,et al. Effects of guided random sampling of TCCs on blood flow values in CT perfusion studies of lung tumors. , 2015, Academic radiology.
[19] M. Maurin,et al. REVIEW ARTICLE doi: 10.1111/j.1472-8206.2008.00633.x The Hill equation: a review of its capabilities in pharmacological modelling , 2008 .
[20] Thierry Bastogne,et al. Data-driven modeling and characterization of anti-angiogenic molecule effects on tumoral vascular density , 2015, Biomed. Signal Process. Control..
[21] R. Subramaniam. A defining moment: cultural change in radiology. , 2015, Academic radiology.
[22] C. H. Thng,et al. Assessment of Tumor Blood Flow Distribution by Dynamic Contrast-Enhanced CT , 2013, IEEE Transactions on Medical Imaging.
[23] Hongliang Sun,et al. Assessment of tumor grade and angiogenesis in colorectal cancer: whole-volume perfusion CT. , 2014, Academic radiology.
[24] D. Sahani,et al. Computed tomography perfusion imaging as a potential imaging biomarker of colorectal cancer. , 2014, World journal of gastroenterology.
[25] D. Sahani,et al. CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression. , 2015, AJR. American journal of roentgenology.
[26] Julia F. Barrett,et al. Artifacts in CT: recognition and avoidance. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.
[27] V. Goh,et al. CT perfusion in oncologic imaging: a useful tool? , 2013, AJR. American journal of roentgenology.
[28] Ramin V. Parsey,et al. Optimal Metabolite Curve Fitting for Kinetic Modeling of 11C-WAY-100635 , 2007, Journal of Nuclear Medicine.
[29] N. Mullani,et al. First-pass measurements of regional blood flow with external detectors. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] H. Tseng,et al. Assessment of Blood Flow in Hepatocellular Carcinoma: Correlations of Computed Tomography Perfusion Imaging and Circulating Angiogenic Factors , 2013, International journal of molecular sciences.
[31] Osamu Okazaki,et al. Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis , 2014, EJNMMI Research.